Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CALL
Boeing
BA
$185B
| $19K | 0.02% |
115,100
-9,300
| -7% | -$1.58M |
|
802
Boston Properties
BXP
$11.1B
| $19K | 0.02% |
236,844
-346,595
| -59% | -$30.3M |
|
|
CERN
803
DELISTED
Cerner Corp
CERN
| $19K | 0.02% |
262,533
+122,703
| +88% | +$8.74M |
|
|
STPK.U
804
DELISTED
Star Peak Energy Transition Corp. Units, each consisting of one share of Class A common stock, and o
STPK.U
| $19K | 0.02% |
+1,850,000
| New | +$18.7M |
|
805
TC Energy
TRP
$65.9B
| $19K | 0.02% |
451,035
+67,355
| +18% | +$3.08M |
|
806
Idacorp
IDA
$8.2B
| $18.9K | 0.02% |
236,864
+81,739
| +53% | +$7.2M |
|
|
BERY
807
DELISTED
Berry Global Group, Inc.
BERY
| $18.8K | 0.02% |
423,882
-472,145
| -53% | -$21.6M |
|
808
American Express
AXP
$230B
| $18.7K | 0.02% |
186,988
-63,960
| -25% | -$6.29M |
|
809
Ascendis Pharma A/S
ASND
$16.8B
| $18.7K | 0.02% |
121,338
-86,280
| -42% | -$12.4M |
|
|
KDMN
810
DELISTED
Kadmon Holdings, Inc.
KDMN
| $18.7K | 0.02% |
4,758,388
+2,538,385
| +114% | +$10.7M |
|
|
INAQU
811
DELISTED
INSU Acquisition Corp. II Unit
INAQU
| $18.6K | 0.02% |
+1,800,000
| New | +$18.9M |
|
812
Dropbox
DBX
$8.12B
| $18.6K | 0.02% |
964,088
-1,562,250
| -62% | -$32.5M |
|
813
Fate Therapeutics
FATE
$326M
| $18.5K | 0.02% |
463,946
-676,289
| -59% | -$23.6M |
|
814
BioNTech
BNTX
$23.5B
| $18.5K | 0.02% |
267,730
+99,632
| +59% | +$7.15M |
|
|
FTIVU
815
DELISTED
FinTech Acquisition Corp. IV Unit
FTIVU
| $18.5K | 0.02% |
+1,820,290
| New | +$18.6M |
|
816
MarketAxess Holdings
MKTX
$5.72B
| $18.5K | 0.02% |
38,378
-23,750
| -38% | -$11.7M |
|
817
CALL
Autodesk
ADSK
$52.6B
| $18.5K | 0.02% |
80,000
+56,900
| +246% | +$13.5M |
|
|
ZGNX
818
DELISTED
Zogenix, Inc.
ZGNX
| $18.5K | 0.02% |
1,030,624
+326,775
| +46% | +$8.01M |
|
819
Alaska Air
ALK
$5.58B
| $18.4K | 0.02% |
503,532
+182,642
| +57% | +$6.84M |
|
820
PUT
Sherwin-Williams
SHW
$89.8B
| $18.4K | 0.02% |
79,200
| – | – |
|
821
Teladoc Health
TDOC
$1.3B
| $18.4K | 0.02% |
83,820
-568,426
| -87% | -$120M |
|
822
CareDx
CDNA
$2.42B
| $18.3K | 0.02% |
483,397
+4,471
| +0.9% | +$151K |
|
823
Envista
NVST
$4.52B
| $18.3K | 0.02% |
739,619
+548,270
| +287% | +$12.6M |
|
824
Castle Biosciences
CSTL
$979M
| $18.3K | 0.02% |
354,731
+6,803
| +2% | +$303K |
|
825
KeyCorp
KEY
$24.4B
| $18.2K | 0.02% |
1,529,484
+1,444,045
| +1,690% | +$17.6M |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.